Gould Robert J sold Fulcrum Therapeutics ($FULC) shares on the open market four times over the past year for a total of $668 thousand. His latest sale occurred on February 2, 2026. These insider sales rank 5,860th among nearly 12,000 individuals, well below the average of $8.6 million and six transactions per insider. Gould Robert J made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | S | Common Stock | 15000 | $10.72 | 454,864.0000 | 62,597,000 | 3.19% | 0.02% |
| Jan. 2, 2026 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | S | Common Stock | 15000 | $10.87 | 469,864.0000 | 62,597,000 | 3.09% | 0.02% |
| Jan. 2, 2026 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | S | Common Stock | 15000 | $11.87 | 469,864.0000 | 62,597,000 | 3.09% | 0.02% |
| Nov. 19, 2025 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | S | Common Stock | 15000 | $11.03 | 484,864.0000 | 62,597,000 | 3.00% | 0.02% |
| June 26, 2025 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 61,984 | 9999.99% | 58.08% |
| June 3, 2024 | Turnstone Biologics Corp. | $TSBX | Gould Robert J | Not found | A | Stock Option (Right to Buy) | 12770 | $0.00 | 12,770.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Gould Robert J | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 61,310 | 9999.99% | 48.93% |